(May 29, 2009 - Insidermedicine) From the UK - According to research in The Lancet, aspirin does not appear to be beneficial for primary prevention of cardiovascular events. In a meta-analysis involving over 95,000 participants, researchers found that long-term, low-dose aspirin did not provide any clear value for primary prevention of cardiovascular events in healthy adults. The researchers suggest that current guidelines may need to be reviewed.

From Washington - U.S. health officials are reporting that preliminary work is being done on a vaccine for the H1N1 swine flu. However, the vaccine will not likely be ready for widespread use until October. To date, there have been 8,585 probable and confirmed cases of the H1N1 strain in the U.S., with 12 deaths and 507 hospitalizations.

And finally, from Belfast - According to research in The Lancet, the incidence of type 1 diabetes is increasing among European children. The research has shown that the incidence is increasing by about 4% each year among children under 15, and new cases in those under 5 could double by 2020. These increasing rates could have significant implications for healthcare resources.

For Insidermedicine in 60, I'm Dr. Susan Sharma.